US equities
|
MU
$910.08
▲+0.57%
NVDA
$216.93
▼-0.07%
SPCX
$147.60
▼-0.24%
TSLA
$374.34
▲+1.71%
META
$690.86
▼-2.07%
SNDK
$1,383.43
▲+0.90%
INTC
$92.60
▲+0.62%
AMZN
$262.97
▲+0.20%
MU
$910.08
▲+0.57%
NVDA
$216.93
▼-0.07%
SPCX
$147.60
▼-0.24%
TSLA
$374.34
▲+1.71%
META
$690.86
▼-2.07%
SNDK
$1,383.43
▲+0.90%
INTC
$92.60
▲+0.62%
AMZN
$262.97
▲+0.20%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Marco Algorta
Recent news which mentions Marco Algorta
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
Tags
Benzinga
Marco Algorta
Benzinga Cannabis Insider
From
Benzinga
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
November 22, 2022
Tickers
NUMIF
NVMDF
Tags
Markets
Ketamine
Health Care
From
Benzinga
Psychedelics To Treat Addictions: 'Patients Arrive Dragging Chains And Leave Making Jokes,' Says This Expert
September 29, 2022
Tags
Marco Algorta
El Planteo
Benzinga
From
Benzinga